Innovative Research Award

Yuanyuan Qiao
University of Michigan, United States

Yuanyuan Qiao
Affiliation University of Michigan
Country United States
Scopus ID 56018160800
Documents 42
Citations 2,091
h-index 21
Subject Area Prostate Cancer Research
Event World Cell Biologist Awards
Google Scholar dGln_v4AAAAJ

Yuanyuan Qiao, affiliated with the University of Michigan in the United States, is recognized in the context of the Innovative Research Award for research associated with prostate cancer. The supplied bibliographic profile identifies 42 documents, 2,091 citations, and an h-index of 21 in Scopus. These metrics provide a quantitative overview of the indexed research record and should be interpreted in relation to publication field, career stage, collaboration patterns, and database coverage. [1]

Abstract

Yuanyuan Qiao of the University of Michigan in relation to the Innovative Research Award at the World Cell Biologist Awards. The profile focuses on the supplied bibliometric record and the stated research subject of prostate cancer research. Scopus information provided for the profile reports 42 indexed documents, 2,091 citations, and an h-index of 21. [1] These indicators describe measurable aspects of scholarly visibility but do not, by themselves, establish the quality, novelty, or clinical significance of individual studies.

Keywords

Yuanyuan Qiao; Innovative Research Award; prostate cancer research; cancer biology; biomedical research; cell biology; oncology; translational research; University of Michigan; research impact; bibliometrics; scholarly publications.

Introduction

Prostate cancer is a major area of biomedical research involving molecular biology, cellular regulation, tumor development, diagnosis, treatment, and disease progression. Contemporary research in this field integrates cellular and molecular approaches with clinical and translational investigation. [4]

Within this broad research environment, scholarly profiles can be evaluated using publication records, citation counts, h-index values, and other indicators. Scopus provides author-level bibliographic information that can assist in examining indexed scholarly output, although bibliometric indicators vary according to database coverage and citation practices between disciplines. [1]

Research Profile

Yuanyuan Qiao with the University of Michigan and identifies prostate cancer research as the principal subject area for this recognition profile. The Scopus author identifier supplied for the researcher is 56018160800. The corresponding indexed record reports 42 documents, 2,091 citations, and an h-index of 21. [1]

Research Contributions

Yuanyuan Qiao’s research within prostate cancer research, a multidisciplinary field in which cellular and molecular mechanisms are relevant to understanding tumor biology and developing improved approaches to disease management. [4] Because specific publications, experimental findings, patents, clinical studies, or research projects were not supplied for this profile, individual scientific contributions are not assigned beyond the documented subject-area classification.

Publications

The supplied data indicate 42 documents indexed in Scopus. [1] A complete publication-by-publication bibliography was not included in the source information provided for this article; therefore, individual article titles, journals, publication years, authorship positions, and DOI identifiers are not attributed to Yuanyuan Qiao without direct bibliographic evidence.

Research Impact

Based on the supplied Scopus figures, the research profile has accumulated 2,091 citations across 42 indexed documents and has an h-index of 21. [1] These indicators suggest measurable citation visibility within the indexed scholarly literature. However, citation-based measures should be considered alongside qualitative evidence, including research originality, methodological contribution, reproducibility, collaboration, societal relevance, and influence on subsequent research.

Award Suitability

The supplied profile is presented for consideration under the Innovative Research Award of the World Cell Biologist Awards. Its documented alignment with prostate cancer research, together with the supplied bibliometric record, provides a basis for presenting the researcher as a candidate within an academic recognition context. [3]

Award suitability should ultimately be determined using the official award criteria and the complete nomination or application materials, including the originality of the research, significance of findings, quality of publications, evidence of scientific contribution, and broader impact. [5]

Conclusion

Yuanyuan Qiao’s supplied academic profile identifies a research affiliation with the University of Michigan and a subject focus in prostate cancer research. The reported Scopus record comprises 42 documents, 2,091 citations, and an h-index of 21. [1] These indicators provide a concise quantitative description of the indexed research record, while a comprehensive assessment of innovative research should also incorporate the scientific content and documented influence of the underlying work. [2]

References

    1. Elsevier. (n.d.). Scopus author details: Yuanyuan Qiao, Author ID 56018160800. Scopus.
      https://www.scopus.com/pages/authors/56018160800
    2. C Cheng, J Hu, R Mannan, Y Qiao, & et al. (2025). Targeting PIKfyve-driven lipid metabolism in pancreatic cancer.
      https://www.nature.com/articles/s41586-025-08917-z
    3. T He, L Xiao, Y Qiao, & et al. (2024). Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies.
      https://www.cell.com/cancer-cell/fulltext/S1535-6108(24)00231-9
    4. Y Bao, Y Qiao, JE Choi, & et al (2023). Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.
      https://www.pnas.org/doi/abs/10.1073/pnas.2314416120
    5. L Xiao, A Parolia, Y Qiao, & et al. (2022). Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.
      https://www.nature.com/articles/s41586-021-04246-z
Yuanyuan Qiao | Prostate Cancer Research | Innovative Research Award

You May Also Like